Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
"Luminous Path, Shared Stride - Brazil and China" 2025-06-16 20:08
WuXi AppTec Recognized by Extel 2025 Asia Executive Team Rankings with Top Honors 2025-06-16 20:00
Flat Medical Partners with Mercury Medical for US Distribution of EpiFaith Smart Syringe 2025-06-16 20:00
PATHOLOGICAL COMPLETE RESPONSE RECORDED IN PATIENT FROM ACCENT CANCER TRIAL 2025-06-16 19:00
NUZ-001 Shows Promise in Zebrafish Model of Huntington's Disease 2025-06-16 19:00
Innovent Announces Completion of First Participant Dosed in the Seventh Phase 3 Clinical Trial (GLORY-OSA) of Mazdutide in China 2025-06-16 10:56
SDP Japan Raises $31 Million in Series D Round 2025-06-16 10:00
Subgroup Analysis of Cadonilimab as First-Line Therapy for Advanced Cervical Cancer Reported in an Oral Presentation at ASCO 2025 2025-06-16 09:25
Celltrion announces U.S. FDA approval of additional presentation of STEQEYMA® (ustekinumab-stba), expanding dosing options for pediatric patients 2025-06-16 07:30
Samsung Biologics launches drug screening services, Samsung Organoids 2025-06-16 07:30
SABRE topline results: Cu-64 SAR-Bombesin is effective in detecting prostate cancer recurrence in patients with negative SOC imaging 2025-06-13 21:01
Neurophet Participates in BIO USA 2025: To showcase Brain Imaging Analysis Solutions Including 'Neurophet AQUA AD' 2025-06-13 21:00
U.S. Food & Drug Administration (FDA) Approves Investigational New Drug (IND) Application for Myrio's Lead Product (PHOX2B PC-CAR T) for the Treatment of Neuroblastoma 2025-06-13 19:35
Keymed Biosciences Announces the Latest Clinical Trial Results of CM336 Published in the New England Journal of Medicine 2025-06-13 17:02
PharmaResearch Spin-Off into Holding and Aesthetics Companies Approved by Board of Directors 2025-06-13 14:21
Innovent to Present Multiple R&D Results of General Biomedicine Pipeline at the ADA's 85th Scientific Sessions 2025-06-13 09:00
Specialised Therapeutics Expands Partnership with Incyte to Include Two Additional Therapies for Hard-to-Treat Conditions 2025-06-13 00:01
Turning Partnerships into Global Healthcare Solutions with VARON Oxygen Solutions 2025-06-12 20:50
Nona Biosciences and Visterra Partner to Advance Next-Generation Biotherapeutics for Immune-Mediated and Autoimmune Diseases 2025-06-12 20:03
Dizal Showcases Two First-in-Class Therapies in Hematologic Malignancies at EHA and ICML 2025 2025-06-12 18:13
1 27 28 29 30 31 491